(PATH) Uipath - NYSE
Sector: Technology | Industry: Software - Infrastructure | Exchange: NYSE (USA) | Market Cap: 5.466m USD | Total Return: -16% in 12m
Avg Turnover: 522M
EPS Trend: 89.6%
Qual. Beats: 0
Rev. Trend: 97.9%
Qual. Beats: 5
Warnings
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
UiPath, Inc. (NYSE: PATH) is a software company that provides an automation platform offering robotic process automation (RPA) solutions and related enterprise automation tools. The company is headquartered in New York, was founded in 2005, and went public in April 2021. UiPath operates primarily in the United States, Romania, the United Kingdom, and the Netherlands, with additional international presence, and is classified within the Information Technology sector under the Systems Software sub-industry.
The UiPath platform is an integrated enterprise software suite that combines AI agents, software robots, human users, and AI models within coordinated workflows. Its product set spans process orchestration and intelligence (UiPath Maestro), an agent builder, RPA and API automation, intelligent document extraction, a test cloud for quality assurance, prebuilt packaged solutions, and centralized governance. The company serves customers across financial services, healthcare, manufacturing, retail, and the public sector.
UiPaths business model is based on selling enterprise software subscriptions and platform licenses, typically on a multi-year contract basis, with RPA representing a category of software that automates repetitive, rules-based digital tasks traditionally performed by humans. The companys recent emphasis on agentic automation - integrating AI agents capable of more autonomous decision-making alongside traditional robotic automation - reflects a broader industry shift from pure task-based RPA toward orchestration platforms that combine AI, machine learning, and human oversight.
- Subscription revenue growth decelerates amid enterprise spending caution
- Microsoft Power Automate competition pressures RPA market share
- AI agent builder adoption expands deal sizes and customer wallet
| Net Income: 327.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 1.08 > 1.0 |
| NWC/Revenue: 59.80% < 20% (prev 96.05%; Δ -36.25% < -1%) |
| CFO/TA 0.13 > 3% & CFO 384.1m > Net Income 327.4m |
| Net Debt (-1.23b) to EBITDA (160.2m): -7.65 < 3 |
| Current Ratio: 2.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (527.8m) vs 12m ago -3.76% < -2% |
| Gross Margin: 82.96% > 18% (prev 82.40%; Δ 0.57% > 0.5%) |
| Asset Turnover: 60.27% > 50% (prev 54.88%; Δ 5.40% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.34 (Total Current Assets 1.83b - Total Current Liabilities 831.7m) / Total Assets 2.90b |
| B: -0.58 (Retained Earnings -1.68b / Total Assets 2.90b) |
| C: 0.05 (EBIT TTM 138.9m / Avg Total Assets 2.77b) |
| D: 1.90 (Book Value of Equity 1.90b / Total Liabilities 1.00b) |
| Altman-Z'' = 2.70 = A |
| DSRI: 0.98 (Receivables 417.1m/371.2m, Revenue 1.67b/1.45b) |
| GMI: 0.99 (GM 82.40% / 82.96%) |
| AQI: 2.05 (AQ_t 0.33 / AQ_t-1 0.16) |
| SGI: 1.15 (Revenue 1.67b / 1.45b) |
| TATA: -0.02 (NI 327.4m - CFO 384.1m) / TA 2.90b) |
| Beneish M = -2.32 (Cap -4..+1) = BBB |
As of June 22, 2026, the stock is trading at USD 10.27 with a total of 45,204,618 shares traded.
Over the past week, the price has changed by -3.57%,
over one month by -2.84%,
over three months by -15.33% and
over the past year by -16.03%.
Uipath has received a consensus analysts rating of 3.17. Therefore, it is recommended to hold PATH.
- StrongBuy: 3
- Buy: 1
- Hold: 18
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 13.3 | 29.6% |
P/E Trailing = 17.5833
P/E Forward = 13.2626
P/S = 3.2686
P/B = 2.8724
P/EG = 0.3792
Revenue TTM = 1.67b USD
EBIT TTM = 138.9m USD
EBITDA TTM = 160.2m USD
Long Term Debt = 72.0m USD (estimated: total debt 83.0m - short term 11.0m)
Short Term Debt = 11.0m USD (from shortTermDebt, last quarter)
Debt = 83.0m USD (from shortLongTermDebtTotal, last quarter) (leases 83.0m already included)
Net Debt = -1.23b USD (calculated: Debt 83.0m - CCE 1.31b)
Enterprise Value = 4.24b USD (5.47b + Debt 83.0m - CCE 1.31b)
Interest Coverage Ratio = unknown (Ebit TTM 138.9m / Interest Expense TTM 0.0)
EV/FCF = 11.30x (Enterprise Value 4.24b / FCF TTM 375.2m)
FCF Yield = 8.85% (FCF TTM 375.2m / Enterprise Value 4.24b)
FCF Margin = 22.44% (FCF TTM 375.2m / Revenue TTM 1.67b)
Net Margin = 19.58% (Net Income TTM 327.4m / Revenue TTM 1.67b)
Gross Margin = 82.96% ((Revenue TTM 1.67b - Cost of Revenue TTM 284.9m) / Revenue TTM)
Gross Margin QoQ = 81.13% (prev 84.88%)
Tobins Q-Ratio = 1.46 (Enterprise Value 4.24b / Total Assets 2.90b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 83.0m)
Taxrate = 45.02% (18.4m / 41.0m)
NOPAT = 76.4m (EBIT 138.9m * (1 - 45.02%))
Current Ratio = 2.20 (Total Current Assets 1.83b / Total Current Liabilities 831.7m)
Debt / Equity = 0.04 (Debt 83.0m / totalStockholderEquity, last quarter 1.90b)
Debt / EBITDA = -7.65 (Net Debt -1.23b / EBITDA 160.2m)
Debt / FCF = -3.27 (Net Debt -1.23b / FCF TTM 375.2m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.80% (Net Income 327.4m / Total Assets 2.90b)
RoE = 17.29% (Net Income TTM 327.4m / Total Stockholder Equity 1.89b)
RoCE = 7.07% (EBIT 138.9m / Capital Employed (Equity 1.89b + L.T.Debt 72.0m))
RoIC = 3.82% (NOPAT 76.4m / Invested Capital 2.00b)
WACC = 11.26% (E(5.47b)/V(5.55b) * Re(11.43%) + D(83.0m)/V(5.55b) * Rd(0.0%) * (1-Tc(0.45)))
Discount Rate = 11.43% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.67 | Cagr: -4.34%
[DCF] Terminal Value 69.16% ; FCFF base≈350.3m ; Y1≈401.6m ; Y5≈591.1m
[DCF] Fair Price = 15.64 (EV 5.87b - Net Debt -1.23b = Equity 7.09b / Shares 453.4m; r=11.26% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 89.59 | EPS CAGR: 20.34% | SUE: -0.18 | # QB: 0
Revenue Correlation: 97.93 | Revenue CAGR: 12.72% | SUE: 2.43 | # QB: 5
EPS current Quarter (2026-07-31): EPS=0.15 | Chg30d=-1.93% | Revisions=+26% | Analysts=19
EPS next Quarter (2026-10-31): EPS=0.19 | Chg30d=-0.64% | Revisions=+18% | Analysts=19
EPS current Year (2027-01-31): EPS=0.79 | Chg30d=-2.06% | Revisions=+33% | GrowthEPS=+9.0% | GrowthRev=+10.4%
EPS next Year (2028-01-31): EPS=0.91 | Chg30d=+0.79% | Revisions=+57% | GrowthEPS=+15.5% | GrowthRev=+8.4%
[Analyst] Revisions Ratio: +57%